Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Health Care Loser
The
sector closed the day up 0.4%.
Catalyst Pharmaceutical Partners Inc
(
),
(
),
(
), and
Five Star Quality Care Incorporated
(
) were all decliners today within the health care sector with
(
) being today's featured health care loser. Regeneron Pharmaceuticals Inc fell 77 cents (-1.4%) to $55.66 on light volume. Throughout the day, 789,106 shares of Regeneron Pharmaceuticals Inc exchanged hands as compared to its average daily volume of 1.5 million shares.
Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions in the United States. Regeneron Pharmaceuticals Inc has a market cap of $5.2 billion and is part of the
industry. Shares are up 71.9% year to date as of the close of trading on Thursday.
TheStreet Ratings rates Regeneron as a
. The company's strengths can be seen in multiple areas, such as its solid stock price performance and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and disappointing return on equity.
- You can view the full Regeneron Ratings Report.
On the positive front,
(
),
(
),
(
), and
(
) were all gainers within the health care sector with
(
) being today's featured health care sector winner.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider
Health Care Select Sector SPDR
(
) while those bearish on the health care sector could consider
ProShares Ultra Short Health Care
(
).
- Find other investment ideas from our top rated ETFs lists.
null
